Houston again anointed the most diverse city in the U.S. by new report

We're No. 1

Houston is once again the most diverse city in America, says a new report. Photo by Zview/Getty Images

Diversity is currently at the forefront of the U.S. conversation, as anti-Asian hate crimes have spiked nearly 150 percent in 2021 and the Derek Chauvin trial currently broils in Minneapolis.

But now, a new study sheds some good news on the Bayou City, as Houston has once again claimed its title as the most diverse city in America. Finance website WalletHub released its report on 2021's Most Diverse Cities in America, and Houston tops out not only as the most diverse city, but also as the most diverse big city in the U.S.

To crown the diversity champion, WalletHub compared the profiles of more than 500 of the largest cities across five major diversity categories: socioeconomic, cultural, economic, household, and religious.

The annual report drills down into metrics and creates a point system on items such as industry diversity, income, age, religious affiliation, education, language, worker class, and marital status.

Towards that end, here's a breakdown of Houston's rankings (with 1 equaling most diverse and 250 equaling "average"):

  • 49th – educational-attainment diversity
  • 40th – racial and ethnic diversity
  • 26th – linguistic diversity
  • 246th – birthplace diversity
  • 15th – industry diversity
  • 173rd – occupational diversity
  • 228th – marital-status diversity

While not standing out in any one particular measurable, Houston narrowly edged out Jersey City, New Jersey with an overall diversity score of 71.87; Jersey City scored a 71.7. The next major city behind Houston is New York City at No. 3 (71.59).

Dallas follows closely behind at No. 4 overall and a ranking of 71.52. Dallas scored best in religious diversity (43rd overall) and cultural diversity (43rd overall), followed by socioeconomic diversity (68th), household diversity (159), and economic diversity (190).

Elsewhere in Texas, Arlington follows at No. 8 overall and a score of 71.19. The city scored best in cultural diversity (38) and religious diversity (90), followed by socioeconomic diversity (111), economic diversity (117), and household diversity (237).

Fort Worth comes in at No. 25 and a score of 70.12. It scored best in cultural diversity (60), followed by socioeconomic diversity (95), economic diversity (119), religious diversity (161), and household diversity (245).

Meanwhile, Austin ranked 38th overall with a score of 69.67. The Capital City scored an impressive No. 3 overall in socioeconomic diversity, followed by cultural diversity (74), household diversity (192), economic diversity (205), and religious diversity (253).

Further down the list is San Antonio at No. 66 overall and a 68.6 score. San Antonio scored best in household diversity (92), followed by religious diversity (102), cultural diversity (137), economic diversity (143), and socioeconomic diversity (205).

Houston's top ranking should come to no surprise to locals. The city topped WalletHub's diversity ranking in 2019.

------

This article originally ran on CultureMap.

The Bayou City has staked its claim as most diverse city in the nation. Photo by Tim Leviston/Getty Images

Houston crowned most diverse city in America by new report

We're No. 1

Last year, many locals cried foul when Houston was named the No. 2 most diverse city in the nation, behind — gasp! — Jersey City, New Jersey. But a new report confirms what we here already know: Houston is, indeed, the most diverse city in the country.

The new ranking comes courtesy of personal finance website WalletHub, which, in 2018, placed Houston in a dubious second place. "Yes, Jersey City may be listed as more ethnically diverse," Dr. Stephen Klineberg, noted local demographic expert, told CultureMap last year. "But it's much smaller." (Some consolation: Last year's WalletHub report found Houston was the most diverse big city in America.)

To crown the diversity champion, WalletHub compared 501 of the most populated cities in America across five key dimensions: socioeconomic diversity, cultural diversity, economic diversity, household diversity, and religious diversity. The report drills down into metrics such as industry diversity, income, age, religious affiliation, education, language, worker class, and marital status.

While not standing out in any one category, Houston toppled Jersey City by achieving an overall diversity score of 71.6; Jersey City scored a 71.52. Houston scored best in industry diversity (No. 16) and racial and ethnic diversity (No. 33), while scoring lowest in marital status diversity (No. 226).

Elsewhere in Texas, Dallas comes in at No. 5 overall, with an overall ranking of 71.12. Arlington follows at No. 9, with an overall ranking of 70.87. Fort Worth comes in at No. 25, with an overall score of 69.88. Further down the list is Austin at No. 42, with an overall score of 69.2. Plano comes in at No. 57, with an overall score of 68.55, while San Antonio follows at No. 62 with an overall score of 68.42.

The least diverse city in America? The scenery apparently doesn't change much in Provo, Utah, which comes in last on WalletHub's list.

------

This article originally ran on CultureMap.



2019's Most Diverse Cities in the U.S.www.youtube.com

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings